Bristol-Myers Squibb Co. is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. More details at: http://www.bms.com.

Should Bristol-Myers Squibb shares be given the Best Value Stocks label? To start, we see that the recent trading price for BMY stock is $57.13 and the dividend yield is 4.41% (as of 6/12/2026). The most recent quarter's (MRQ) earnings result, annualized, was $6.32/share. Looking at the sum total of quarterly earnings across the trailing twelve month (TTM) period, Bristol-Myers Squibb produced $5.93/share. And taking the median quarterly result across the TTM period, and annualizing it, results in $6.08/share. Comparing the current indicated annual dividend rate of $2.52 against that median result, we calculate a dividend payout ratio of 41.4%. Comparing the company's various earnings metrics against the stock price, we end up with a PE ratio of 9.4 for the TTM Median method, 9.0 for price to earnings using MRQ annualized, and 9.6 for current price/TTM earnings. Based on BMY's history, that recent TTM PE is low relative to the historical average, with the recent PE 48.9% lower than the average (TTM method) of 18.8.

HP Inc. is a global provider of personal computing and other digital access devices, imaging and printing products, and related technologies, solutions and services. Co. delivers a range of devices, services and subscriptions for personal computing, printing, three-dimensional (3D) printing, hybrid work, gaming, and more. It operates in three segments. The Personal Systems segment offers commercial and consumer desktops and notebooks, detachables and convertibles, workstations, thin clients, commercial mobility devices, retail point-of-sale (POS) systems, displays, hybrid systems, software, solutions, and services. More details at: http://www.hp.com.

Should HP shares be given the Best Value Stocks label? To start, we see that the recent trading price for HPQ stock is $25.24 and the dividend yield is 4.75% (as of 6/12/2026). The most recent quarter's (MRQ) earnings result, annualized, was $3.44/share. Looking at the sum total of quarterly earnings across the trailing twelve month (TTM) period, HP produced $3.35/share. And taking the median quarterly result across the TTM period, and annualizing it, results in $3.32/share. Comparing the current indicated annual dividend rate of $1.20 against that median result, we calculate a dividend payout ratio of 36.1%. Comparing the company's various earnings metrics against the stock price, we end up with a PE ratio of 7.6 for the TTM Median method, 7.3 for price to earnings using MRQ annualized, and 7.5 for current price/TTM earnings. Based on HPQ's history, that recent TTM PE is low relative to the historical average, with the recent PE 5.1% lower than the average (TTM method) of 7.9.

Pfizer Inc. is a research-based global biopharmaceutical company. Co. is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. More details at: http://www.pfizer.com.

Should Pfizer shares be given the Best Value Stocks label? To start, we see that the recent trading price for PFE stock is $26.21 and the dividend yield is 6.56% (as of 6/12/2026). The most recent quarter's (MRQ) earnings result, annualized, was $3/share. Looking at the sum total of quarterly earnings across the trailing twelve month (TTM) period, Pfizer produced $3.06/share. And taking the median quarterly result across the TTM period, and annualizing it, results in $3.08/share. Comparing the current indicated annual dividend rate of $1.72 against that median result, we calculate a dividend payout ratio of 55.8%. Comparing the company's various earnings metrics against the stock price, we end up with a PE ratio of 8.5 for the TTM Median method, 8.7 for price to earnings using MRQ annualized, and 8.6 for current price/TTM earnings. Based on PFE's history, that recent TTM PE is low relative to the historical average, with the recent PE 29.5% lower than the average (TTM method) of 12.2.

The Progressive Corporation is an insurance holding company, which has insurance and non-insurance subsidiaries and affiliates. Co.'s segments include Personal Lines, Commercial Lines, Property and Other indemnity. The Personal Lines segment writes insurance for personal autos and recreational vehicles. The segment consists of personal auto and special lines products. Commercial Lines segment writes auto-related liability and physical damage insurance, business-related general liability and property insurance predominately for small businesses, and workers' compensation insurance primarily for the transportation industry. More details at: http://www.progressive.com.

Should Progressive shares be given the Best Value Stocks label? To start, we see that the recent trading price for PGR stock is $203.11 and the dividend yield is 0.20% (as of 6/12/2026). The most recent quarter's (MRQ) earnings result, annualized, was $19.84/share. Looking at the sum total of quarterly earnings across the trailing twelve month (TTM) period, Progressive produced $18.57/share. And taking the median quarterly result across the TTM period, and annualizing it, results in $19.12/share. Comparing the current indicated annual dividend rate of $0.40 against that median result, we calculate a dividend payout ratio of 2.1%. Comparing the company's various earnings metrics against the stock price, we end up with a PE ratio of 10.6 for the TTM Median method, 10.2 for price to earnings using MRQ annualized, and 10.9 for current price/TTM earnings. Based on PGR's history, that recent TTM PE is low relative to the historical average, with the recent PE 45.5% lower than the average (TTM method) of 20.0.

PayPal Holdings, Inc. offers a technology platform that enables digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its payment solutions enable its customers to connect, transact, and send and receive payments, whether they are online or in person. It provides payment solutions accepted by merchants that enable the completion of payments on its platform on behalf of its customers. It operates a global, two-sided network at scale that connects merchants and consumers with 426 million active accounts across 200 markets. Its brands include PayPal, Braintree, Venmo, Xoom, Hyperwallet, PayPal Zettle, PayPal Honey, and Paidy. More details at: http://www.paypal.com.

Should PayPal Holdings shares be given the Best Value Stocks label? To start, we see that the recent trading price for PYPL stock is $41.52 and the dividend yield is 1.35% (as of 6/12/2026). The most recent quarter's (MRQ) earnings result, annualized, was $5.36/share. Looking at the sum total of quarterly earnings across the trailing twelve month (TTM) period, PayPal Holdings produced $5.31/share. And taking the median quarterly result across the TTM period, and annualizing it, results in $5.36/share. Comparing the current indicated annual dividend rate of $0.56 against that median result, we calculate a dividend payout ratio of 10.4%. Comparing the company's various earnings metrics against the stock price, we end up with a PE ratio of 7.7 for the TTM Median method, 7.7 for price to earnings using MRQ annualized, and 7.8 for current price/TTM earnings. Based on PYPL's history, that recent TTM PE is low relative to the historical average, with the recent PE 74.3% lower than the average (TTM method) of 30.4.